INTRODUCTION
Congenital Pulmonary Airway Malformation (CPAM) is a rare hamartomatous lung lesion and is also known as congenital cystic adenomatoid malformation (CCAM). It was first described by Ch'in and Tang in 1949. 1 It is characterized by abnormal embryogenesis in the form of overgrowth of terminal bronchioles (adenomatoid) at the expense of alveolar spaces. CPAM comprises of heterogeneous group of cystic and solid/microcystic lung lesions. The microcystic lesions are invariably fatal 2 as they cause non-immune hydrops fetalis. The hydrops fetus will place the mother at a slightly increased risk for "mirror syndrome". Mirror syndrome (Ballantyne's syndrome) is defined as the development of maternal edema in association with fetal hydrops. John W. Ballantyne 3 in 1892 was the first to describe the association of maternal edema in pregnancy with fetal hydrops due to rhesus isoimmunization. We report here such a rare case of microcystic CPAM causing non immune hydrops fetalis and mirror syndrome.
CASE REPORT
A 20-year-old primigravida was referred to the department of obstetrics at 26 weeks of gestation with gestational hypertension, pedal edema, moderate anemia, mild proteinuria and with suspicion of a non-immune fetal hydrops.
Ultrasonography revealed fetal ascites, cardiac shift to right side, large hyper-echogenic edematous left lung and moderate hydromnios ( Figure 1a , 1b and 1c). The bad fetal prognosis and maternal morbidity were explained to the parents and they opted for termination of pregnancy. The 26-week male fetus was delivered by using inducing agents and sent for fetal autopsy. Based on histopathology, a final diagnosis of Congenital Pulmonary Airway Malformation (CPAM) type III was considered.
DISCUSSION
Congenital Pulmonary Airway Malformation (CPAM) is a rare developmental abnormality of lung. Incidence being 1 in 25000 to 35000 pregnancies. 4 Males are affected slightly more common than females. CPAM usually involves an entire lung or a single lobe or rarely involve the both lungs and this abnormal tissue will never function as normal lung tissue. The natural history of CPAM is likely related to its growth pattern during embryologic development. Lesion growth may increase or plateau during gestation. The size of lesions and variable growth behavior results in either absence of symptoms/development of non-immune hydrops fetalis.
Causes 5, 6 The underlying cause of CPAM is unknown.
 Resected CCAMs show signs of increased cell proliferation and decreased apoptosis.
 Studies have investigated the role of HOXB5 gene and protein expression, as well as other growth factors such as mesenchymal platelet-derived growth factor-BB.
 As development of the respiratory system begins at 3 weeks of gestation, and as a consequence of abnormal embryogenesis during the first 6-7 weeks of pregnancy, involving maldevelopment of terminal bronchioles leads to CPAM.
Although the routine antenatal imaging studies may suggest the possibility of CPAM, histopathological examination remains the main stay of diagnosis. Diagnostic criteria include: Stocker has divided CCAM into five different categories based on the proposed site of defect in the tracheobronchial tree. 
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Type III (microcystic) Solid lesions <0.5 cm size. Irregular curving channels and small air spaces lined by plumb cuboidal epithelium.
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Type IV Large air filled cysts. Multilocular, large cysts lined by flattened alveolar lining cells.
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These lesions may be asymptomatic, or can lead to enlarged abnormal lung tissue, causing s hypoplasia of normal lung, mediastinal shift, cardiovascular compromise and fetal cardiac failure leading to nonimmune fetal hydrops.
The hydrops fetus will place the mother at a slightly increased risk for "mirror syndrome."
Treatment depends on the size of the lesion and complications.
Treatment of choice for CPAM is lobectomy, performed at approximately 2 to 6 months of age. Thoracocentesis allows drainage of a large cyst with immediate decompression of the CPAM. Fetal surgery (thoracoamniotic shunt) that continually drains fluid from the CPAM to the amniotic space is prefereed in some cases.
Maternal termination of pregnancy is the treatment of choice if CPAM is associated with hydrops fetalis and "mirror syndrome."
CONCLUSIONS
Congenital pulmonary airway malformation is a rare fetal lung anomaly with excellent prognosis in the absence of fetal hydrops. CPAM associated with fetal hydrops carries a grave fetal prognosis and development of "mirror syndrome" calls for immediate delivery of fetus as this condition is potentially life threatening for the mother.
